Potassium Chloride Tablet, Extended Release shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting 2025-11-21 · last update 2025-11-21
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Potassium Chloride, Tablet, Extended Release, 10 meq (NDC 62037-710-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/21/2025 Updated 11/21/2025 Discontinued 11/21/2025 |
| Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/21/2025 Updated 11/21/2025 Discontinued 11/21/2025 |
| Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-05) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/21/2025 Updated 11/21/2025 Discontinued 11/21/2025 |
| Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-10) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/21/2025 Updated 11/21/2025 Discontinued 11/21/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)